CIK 0001422143
- Non-accelerated filer
- Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547851
- Phone
- +1 858-500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $4,248,530
- in 3 filings
- Open-market sales, last 90 days
- $1,310,361
- in 7 filings, $252K under 10b5-1 plans
Net +$2,938,169. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$4.2M President and CEO 3 filings
- Leoni Mollie −$440K Chief Medical Officer sold 23% of stake
- Powl Brian T. −$397K Chief Commercial Officer sold 21% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
- FORD KATHLEEN −$112K Chief Operating Officer sold 7% of stake
Reading 38 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-19 | WILSON TROY EDWARD President and CEO | Exercise or conversion · Option to purchase common stock | −11,913 | 13,728 | ||
| 2020-08-18 | WILSON TROY EDWARD President and CEO | Exercise or conversion | +521 | $4.80 | $3K | 28,617 |
| 2020-08-18 | WILSON TROY EDWARD President and CEO | Sale | −521 | $22.00 | $11K | 28,096 |
| 2020-08-18 | WILSON TROY EDWARD President and CEO | Exercise or conversion · Option to purchase common stock | −521 | 25,641 | ||
| 2020-08-17 | WILSON TROY EDWARD President and CEO | Gift | −26,041 | 28,096 | ||
| 2020-08-17 | WILSON TROY EDWARD President and CEO | Gift | +26,041 | 1,795,017 | ||
| 2020-08-17 | WILSON TROY EDWARD President and CEO | Sale | −50,000 | $22.00 | $1.1M | 356,736 |
| 2020-08-17 | WILSON TROY EDWARD President and CEO | Exercise or conversion | +12,901 | $4.80 | $62K | 40,997 |
| 2020-08-17 | WILSON TROY EDWARD President and CEO | Sale | −12,901 | $22.00 | $284K | 28,096 |
| 2020-08-17 | WILSON TROY EDWARD President and CEO | Exercise or conversion · Option to purchase common stock | −12,901 | 26,162 | ||
| 2020-08-07 | GRASSO MARC CFO, CBO | Exercise or conversion | +7,102 | $15.47 | $110K | 10,000 |
| 2020-08-07 | GRASSO MARC CFO, CBO | Sale | −10,000 | $20.00 | $200K | 0 |
| 2020-08-07 | GRASSO MARC CFO, CBO | Exercise or conversion · Option to purchase common stock | −7,102 | 132,898 | ||
| 2020-06-24 | Parks Diane L. Director | Grant or award · Option to purchase common stock | +23,000 | 23,000 | ||
| 2020-06-24 | Szela Mary T Director | Grant or award · Option to purchase common stock | +23,000 | 23,000 | ||
| 2020-06-24 | Stein Steven H Director | Grant or award · Option to purchase common stock | +23,000 | 23,000 | ||
| 2020-06-24 | Malley Thomas Director | Grant or award · Option to purchase common stock | +23,000 | 23,000 | ||
| 2020-06-24 | Hasnain Faheem Director | Grant or award · Option to purchase common stock | +23,000 | 23,000 | ||
| 2020-06-24 | HOFFMAN ROBERT Director | Grant or award · Option to purchase common stock | +23,000 | 23,000 | ||
| 2020-03-12 | BASTA JAMES Chief Legal Officer | Grant or award · Option to purchase common stock | +25,000 | 25,000 |
Page 16 of 19 · 366 trades